Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer

Key Points

• This research aims to evaluate how prostate-specific membrane antigen imaging influences the treatment decisions for prostate cancer.
• Cohort study design involving patients diagnosed with prostate cancer.
• Assessment of outcomes based on the use of positron emission tomography for treatment planning.
• Increased use of prostate-specific membrane antigen PET correlated with more targeted treatment strategies.
• Analysis suggests potential benefits in treatment effectiveness associated with imaging utilization.